Fox Chase's Breast Cancer Treatment Program Earns Prestigious NAPBC Accreditation for the Third Time

Article

In Partnership With:

Fox Chase Cancer Center's breast cancer program has earned full accreditation for the third time from The National Accreditation Program for Breast Centers.

Fox Chase Cancer Center’s breast cancer program has earned full accreditation for the third time from The National Accreditation Program for Breast Centers (NAPBC), the premier accreditation program for breast centers throughout the United States.

“As one of the first programs to successfully put itself up for evaluation three time by the NAPBC, we are grateful that others agree with what we so often state: you can’t get better breast care than at Fox Chase Cancer Center,” said Richard J. Bleicher, MD, FACS, Associate Attending Surgeon, Breast Clinical Program Leader, and Director of the Breast Fellowship Program at Fox Chase Cancer Center.

Administered by the American College of Surgeons, the NAPBC awards accreditation based on 27 individual standards of breast care extending from benign to malignant disease, and it incorporates evaluation of standards of treatment.

In addition, the NAPBC considers components of care such as coordination of treatment via nurse navigation, support services, the credentials of the clinicians and nurses, and the quality improvement initiatives. This independent evaluation has been demonstrated to correlate with adherence to standard therapies and quality care.

Fox Chase’s breast cancer treatment team offers the most advanced treatment options for breast cancer, and our multi-disciplinary team of nationally-recognized doctors has more experience in treating women with breast cancer than anywhere else in the region,” Bleicher adds. “I am very proud to be connected to such a prestigious organization that works to improve patient care throughout the country.” Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).

Related Videos
A panel of 4 experts on bladder cancer
A panel of 4 experts on bladder cancer
A panel of 4 experts on bladder cancer
A panel of 4 experts on bladder cancer
A panel of 4 experts on bladder cancer
A panel of 4 experts on bladder cancer
A panel of 4 experts on bladder cancer
Matthew Milowsky, MD, FASCO, an expert on bladder cancer
A panel of 4 experts on bladder cancer
A panel of 4 experts on bladder cancer